Full-Time

Staff Electrical Engineer

Confirmed live in the last 24 hours

Valo Health

Valo Health

51-200 employees

Drug discovery using machine learning technology

Compensation Overview

$129k - $158kAnnually

Senior, Expert

New York, NY, USA

Category
Control Systems Engineering
Embedded Systems Engineering
Electrical Engineering
Required Skills
CAD
PSpice
Python
SQL
Java
MATLAB
C/C++
FPGA
Arduino
Requirements
  • Bachelor’s or master’s degree in electrical engineering or related field, preferably with experience or interest in biomedical engineering or medical device development.
  • 7+ years of experience in electrical engineering, with 2+ years in a senior role.
  • Strong programming skills in languages including Python, SQL, C/C++, and Java.
  • Software experience with CAD, PSPICE, and MATLAB.
  • Proficiency with hardware and database libraries as well as versioning of code, data, and system architecture.
  • Experience with microcontrollers, FPGA, and embedded systems as well as power systems, control systems, and signal processing. Understanding of single board microcontrollers such as Arduino are a plus.
  • Rapid prototyping from bread board to PCB with hands on experience with tools including soldering equipment, oscilloscopes, waveform generators and multimeters.
  • Familiarity with SLS or resin printers as well as the ability to surface finish and assemble components are beneficial but no requirement.
  • Excellent communication, leadership, project management, and problem-solving skills.
  • A collaborative and self-driven mindset with the desire to innovate and the capacity to ask questions, provide new ideas or unexpected answers.
  • Approaches problems with a positive attitude, a clear plan, and persistence during follow-through.
  • Familiarity with ISO 13485 and ISO 9001 standards.
  • Proficiency in core statistical concepts, including engineering applications of DOE and control charting.
Responsibilities
  • Lead and execute electrical engineering projects from concept to production, while ensuring timely completion, quality, and budget adherence.
  • Design, develop, and test stimulation infrastructure for Organ-on-a-Chip systems to depolarize cardiac and skeletal tissues during long term incubation and drug experiments.
  • Code back-end instructions for stimulator and front-end user-interfaces, server logs, and result analysis tools to help biologists review stimulation parameters alongside hardware and tissue metrics with full code and architecture ownership end-to-end.
  • Perform circuit design, simulation, and prototyping of waveform generators and execute small batch manufacturing.
  • Monitor performance, troubleshoot electrical issues, and implement corrective actions on existing system architecture including servers, incubators, and microscopes.
  • Guide and mentor colleagues while providing technical support and training as subject matter expert for electrical engineering.
  • Work closely with cross-functional teams (mechanical, software, and biology) to ensure seamless project execution.
  • Collect requirements from users in tissue production prior to product development and document their changes throughout the lifecycle of completed systems.
  • Author and maintain design history files to document product development, compose tests reports during the evaluate of prototypes, and write standard operating procedures prior to batch production.
  • Qualify, on-board, and manage external vendors as well as consultants for a robust supply chain of consumables and custom-made parts, on time.
  • Request quotes, negotiates competitive pricing to source materials, tooling, and supplies from external vendors.
  • Stay up to date with industry trends, emerging technologies, and potential regulatory requirements.
  • Contribute to intellectual property development, patent applications, and research initiatives.
  • Support manufacturing and test components of our biological engineering platform.
Desired Qualifications
  • Creativity, accountability, and leadership with a talent to effectively brainstorm, rigorously probe novel concepts and quickly reach solutions through a strong foundation in engineering fundamentals.
  • An interest in biology with a basic understanding of human physiology and common pathologies such as heart disease.
  • Experience or interest in microfluidics, electro-mechanical, and/or optical systems for microscopy.
  • Experience with KNIME Analytics platform and its use in signal processing, result analysis and graph generation.
  • Knowledgeable in polymer synthesis, characterization, and handling.
  • Experience with CNC machines including the creation of machine paths or troubleshooting hardware.
  • Worked with sterile techniques or in clean room environment.
  • Experience in packaging, labeling, and sterilization of medical products.
  • Technical documentation expertise in risk analysis, and usability files are optional.

Valo Health focuses on drug discovery and development in the biopharmaceutical sector. The company utilizes its Opal Computational platform, which integrates machine learning, tissue biology, and patient data, to create tools that enhance the drug development process. This platform allows Valo Health to identify potential drug candidates more efficiently than traditional methods. Unlike many competitors, Valo Health combines technology with life sciences, enabling it to tackle significant challenges in the industry. The company's goal is to improve health outcomes for patients globally by delivering effective solutions through partnerships with pharmaceutical companies and research institutions.

Company Size

51-200

Company Stage

Late Stage VC

Total Funding

$474.2M

Headquarters

Boston, Massachusetts

Founded

2019

Simplify Jobs

Simplify's Take

What believers are saying

  • Novo Nordisk partnership could yield up to $4.6 billion in milestone payments.
  • AI-driven drug discovery is gaining market traction, benefiting Valo's business model.
  • Valo's large human-centric data library enhances predictive drug development capabilities.

What critics are saying

  • Leadership changes may impact strategic direction and decision-making.
  • Heavy reliance on partnerships poses financial risks if milestones aren't met.
  • Competitive AI-driven drug discovery landscape challenges Valo's market position.

What makes Valo Health unique

  • Valo Health integrates AI and human data for accelerated drug discovery.
  • Opal Computational Platform™ offers a unified architecture for drug development.
  • Focus on cardiovascular, oncology, and neurodegenerative diseases sets Valo apart.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

-7%

1 year growth

-5%

2 year growth

-8%
Valo Health
Jan 24th, 2025
Valo Health Receives $110 Million in Funding From Koch Disruptive…

Valo is a new type of technology company, uniting human and machine intelligence aiming to accelerate the creation of life-changing cures.

BioSpace
Jan 9th, 2025
Novo Puts $4.6B On The Line To Expand Valo Deal, Maintain Cardiometabolic Leadership

Novo Nordisk on Wednesday announced that it will expand a 2023 contract with Boston biotech Valo Health to develop novel treatments for obesity, type 2 diabetes and other cardiometabolic conditions.The expanded deal’s initial consideration involves a total of $190 million in an upfront payment, equity investment and milestones. The partners will be able to work collaboratively on up to 20 drug programs for which milestone payments could reach around $4.6 billion, in addition to R&D funding and potential royalties.Novo and Valo first entered into their partnership in September 2023. At the time, the obesity leader paid $60 million upfront and pledged up to $2.7 billion for the opportunity to collaborate on 11 cardiometabolic programs. At the center of the collaboration is Valo’s AI-enabled preclinical capabilities, which allow the biotech to identify and validate druggable targets, as well as design and screen potentially therapeutic molecules against these targets.Valo says its preclinical edge comes from its proprietary computational platform Opal, which leverages AI models built using high-quality human data. What the biotech calls its “integrated approach” to drug discovery and development generates and uses data at every stage of the process—from disease and target discovery through regulatory approval—producing a “self-reinforcing, active learning system” that improves its performance with each experiment, the company says on its website.Valo claims its human-centric data library is “the largest and densest in the world,” and that models developed using these data can help Valo and its partners predict disease progression “and how a drug will perform before it even touches a person.”For Novo, Valo’s approach appears to be working well. Pharma CSO Marcus Schindler said in a statement on Wednesday that the company is “very pleased with the progress” it has seen under the Valo partnership, leading to its decision to expand the agreement

Rama On Healthcare
Jan 8th, 2025
Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagship's Valo Health

Novo Nordisk's collaboration with artificial intelligence startup Valo Health has focused on developing new drugs for cardiovascular disease.

Reuters
Jan 8th, 2025
Novo Nordisk expands AI partnership with Valo Health for development of obesity drugs

Jan 8 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO) and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to develop new treatments for cardiometabolic diseases using human data and artificial intelligence (AI).

Fierce Biotech
Jan 8th, 2025
Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes

If the programs hit their milestones, Valo could receive $4.6 billion from Novo plus R&D funding and potential royalty payments.